Cite
HARVARD Citation
Salas, Q. et al. (n.d.). Effective treatments are required for patients with diffuse large B‐cell lymphoma (DLBCL) with primary refractory disease. Hematological oncology. p. 344. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Salas, Q. et al. (n.d.). Effective treatments are required for patients with diffuse large B‐cell lymphoma (DLBCL) with primary refractory disease. Hematological oncology. p. 344. [Online].